Skip to Main Content
Our specialists
Find specialists supported by world-renowned researchers & educators.
>
See our specialists
Where to find us
See a map of Clinic Locations
>
Clinical Locations
Referrals
Information for referring doctors
>
Refer a patient

Yale Cancer Center at Smilow Cancer Hospital

Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute—and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.

Fact Sheets

News from Yale Medicine

In the News

Clinical Trials

Lung Cancer

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

AgeANY
GenderANY
Date1 July
Leukemia

A Controlled Multi-Arm Ph1 Study Evaluating the Safety and Feasibility of TCR Engineered Donor TCells Targeting HA1 (TSC-100) or HA2 (TSC-101) in HLA-A0201 Positive Patients Undergoing Haploidentical Allogeneic Stem Cell Transplantation

AgeANY
GenderANY
Date21 August
Prostate Cancer, Phase 1 Cancers

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors

AgeANY
GenderANY
Date1 August
Sarcoma Cancers

A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma

AgeANY
GenderANY
Date19 December